Menu

Evaluating the Functional Potency of Immunotherapies Targeting Tumors of B Cell Origin

Download this application note to learn how the ACEA xCELLigence system can evaluate the potency of an immunotherapy against a broad spectrum of liquid tumors and monitor the destruction kinetics of liquid cancers at physiologically relevant effector:target cell ratios.

Sep 19, 2019
The Scientist Creative Services Team

Evaluating the Functional Potency of Immunotherapies Targeting Tumors of B Cell Origin

October 2019

Brain Fog

Air Pollution May Cause Cognitive Decline

Marketplace

Sponsored Product Updates

How single cell proteomics data can drive CAR-Treg-based therapies—an interview with Leonardo Ferreira
How single cell proteomics data can drive CAR-Treg-based therapies—an interview with Leonardo Ferreira
Leonardo Ferreira, a postdoctoral fellow at the University of California, San Francisco, discusses the application of single cell proteomics data to understanding the function and therapeutic potential of genetically engineered regulatory T cells.